About NEUROTECH USA CORP
Neurotech Pharmaceuticals, Inc. is a private biotech company focused on developing transformative therapies for chronic eye diseases, particularly targeting Macular Telangiectasia Type 2 (MacTel). The company utilizes an Encapsulated Cell Therapy (ECT) platform to deliver Ciliary Neurotrophic Factor (CNTF) for photoreceptor protection.
Development of transformative therapies for chronic eye diseasesEncapsulated Cell Therapy (ECT) platform for delivering Ciliary Neurotrophic Factor (CNTF)Clinical research and studies for new treatment methodsFDA-approved treatment for MacTel
Recent Federal Awards
| Award | Agency | Amount | Date |
|---|---|---|---|
| ENCELTO IMPLANT FOR PATIENT SURGERY | Department of Veterans Affairs | $188K |
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to NEUROTECH USA CORP right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.